Notice of Intent to Sole Source – Miltenyi Biotec, Inc

Description: The National Institutes of Health intends to sole-source one Miltenyi Biotec GentleMACS Octo Dissociator with Heater for its Clinical Pharmacology Laboratory in Bethesda, Maryland. The equipment will automate tissue dissociation and homogenization before LC-MS analysis, supporting pharmacokinetic studies, tissue-distribution studies, biomarker discovery, and PK/PD profiling. This is a presolicitation notice rather than a request for quotation, and comments may be submitted to the NIH before the notice becomes inactive on August 1, 2026.